Carcinoma, Neuroendocrine
"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
MeSH Number(s)
C04.557.465.625.650.240
C04.557.470.200.025.370
C04.557.580.625.650.240
Concept/Terms
Carcinoma, Neuroendocrine- Carcinoma, Neuroendocrine
- Carcinomas, Neuroendocrine
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".
This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 2 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 7 | 10 |
| 2012 | 2 | 4 | 6 |
| 2013 | 3 | 5 | 8 |
| 2014 | 2 | 3 | 5 |
| 2015 | 5 | 2 | 7 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 3 | 6 |
| 2018 | 11 | 1 | 12 |
| 2019 | 21 | 0 | 21 |
| 2020 | 15 | 1 | 16 |
| 2021 | 18 | 0 | 18 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.
-
Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022 Mar; 33(1):27-63.
-
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021 12 21; 12(1):7349.
-
Medullary Thyroid Cancer: 60 Years of Gradual Understanding. Ann Surg Oncol. 2022 01; 29(1):7-8.
-
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. J Clin Oncol. 2022 01 01; 40(1):96-104.
-
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nat Commun. 2021 10 01; 12(1):5775.
-
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. J Pathol. 2021 12; 255(4):425-437.
-
Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy. Thyroid. 2021 10; 31(10):1451-1462.
-
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clin Cancer Res. 2021 09 01; 27(17):4923-4936.
-
Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas. Histopathology. 2021 Sep; 79(3):427-436.
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study. Lancet Diabetes Endocrinol. 2021 08; 9(8):491-501.